EDGAR Filing Documents for 0001628280-18-003872

Form 8-K - Current report:

SEC Accession No. 0001628280-18-003872

Filing Date

2018-03-30

Accepted

2018-03-30 16:59:57

Documents

Period of Report

2018-03-30

Items

Item 8.01: Other Events

Document Format Files

Seq	Description	Document	Type	Size
1	8-K - H. PYLORI PUBLICATION	a8k-hpyloripublication.htm	8-K	32524
2	EXHIBIT 99.1 - PRESS RELEASE - H PYLORI PUBLICATION	pressrelease-hpyloripublic.htm	EX-99.1	25166
3		cumberlanda11.gif	GRAPHIC	10657
	Complete submission text file	0001628280-18-003872.txt		73494

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203

Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068

CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 18726545
SIC: 2834 Pharmaceutical Preparations